BE854908A - Nouvelles aryl trifluoroethylamines, procedes d'obtention et les compositions pharmaceutiques en renfermant - Google Patents

Nouvelles aryl trifluoroethylamines, procedes d'obtention et les compositions pharmaceutiques en renfermant

Info

Publication number
BE854908A
BE854908A BE177800A BE177800A BE854908A BE 854908 A BE854908 A BE 854908A BE 177800 A BE177800 A BE 177800A BE 177800 A BE177800 A BE 177800A BE 854908 A BE854908 A BE 854908A
Authority
BE
Belgium
Prior art keywords
trifluoroethylamines
obtaining
methods
pharmaceutical compositions
compositions containing
Prior art date
Application number
BE177800A
Other languages
English (en)
French (fr)
Original Assignee
Science Union & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Science Union & Cie filed Critical Science Union & Cie
Publication of BE854908A publication Critical patent/BE854908A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/333—Radicals substituted by oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/335—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C07D233/48—Nitrogen atoms not forming part of a nitro radical with acyclic hydrocarbon or substituted acyclic hydrocarbon radicals, attached to said nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D239/08—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
    • C07D239/12—Nitrogen atoms not forming part of a nitro radical
    • C07D239/14—Nitrogen atoms not forming part of a nitro radical with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to said nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/28—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/06—1,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings
    • C07D265/08—1,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/18—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/22—Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom
BE177800A 1976-05-24 1977-05-23 Nouvelles aryl trifluoroethylamines, procedes d'obtention et les compositions pharmaceutiques en renfermant BE854908A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7615601A FR2358890A1 (fr) 1976-05-24 1976-05-24 Nouvelles aryl trifluoroethylamines, leurs procedes d'obtention et les compositions pharmaceutiques en renfermant

Publications (1)

Publication Number Publication Date
BE854908A true BE854908A (fr) 1977-11-23

Family

ID=9173528

Family Applications (1)

Application Number Title Priority Date Filing Date
BE177800A BE854908A (fr) 1976-05-24 1977-05-23 Nouvelles aryl trifluoroethylamines, procedes d'obtention et les compositions pharmaceutiques en renfermant

Country Status (21)

Country Link
US (3) US4267345A (xx)
JP (2) JPS584715B2 (xx)
AR (2) AR219296A1 (xx)
AT (1) AT350062B (xx)
AU (1) AU517715B2 (xx)
BE (1) BE854908A (xx)
CH (1) CH625795A5 (xx)
DE (1) DE2723464C2 (xx)
ES (1) ES459086A1 (xx)
FR (1) FR2358890A1 (xx)
GB (2) GB1564269A (xx)
GR (1) GR61659B (xx)
HU (1) HU177039B (xx)
IL (1) IL52137A (xx)
NL (1) NL169182C (xx)
NZ (1) NZ184175A (xx)
OA (1) OA05668A (xx)
PH (1) PH13880A (xx)
PT (1) PT66584B (xx)
SE (1) SE7705986L (xx)
SU (2) SU725561A3 (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2444673A1 (fr) * 1978-12-20 1980-07-18 Science Union & Cie Nouvelles trifluoroethylamines, leurs procedes d'obtention et leur emploi comme medicament
US4348247A (en) * 1979-02-26 1982-09-07 Rockwell International Corporation Method of fabricating a reinforced tubular structure
DE3465993D1 (en) * 1983-08-11 1987-10-15 Synthelabo Indole derivatives, their preparation and their therapeutical application
JPH06312412A (ja) * 1992-06-10 1994-11-08 Nippon Hume Pipe Co Ltd 模様付き複合コンクリート製品およびその成形方法
AUPP020297A0 (en) * 1997-11-05 1997-11-27 University Of Melbourne, The A novel receptor, and compounds which bind thereto
CA2443906A1 (en) * 2001-04-16 2002-10-24 University Of Virginia Patent Foundation Novel oral general anesthetics and metabolitically resistant anticonvulsants
EP2070923A1 (de) 2007-12-11 2009-06-17 Bayer CropScience AG Insektizide Iminoheterocyclen
UY32940A (es) 2009-10-27 2011-05-31 Bayer Cropscience Ag Amidas sustituidas con halogenoalquilo como insecticidas y acaricidas
AR085509A1 (es) 2011-03-09 2013-10-09 Bayer Cropscience Ag Indol- y bencimidazolcarboxamidas como insecticidas y acaricidas
CN104718206B (zh) 2012-08-17 2017-03-08 拜尔农作物科学股份公司 作为杀虫剂和杀螨剂的氮杂吲哚甲酰胺和氮杂吲哚硫代甲酰胺

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2889351A (en) * 1956-05-25 1959-06-02 Pfizer & Co C Therapeutic agents
US3626067A (en) * 1965-07-01 1971-12-07 Du Pont Substituted oxazolines, useful as pharmaceuticals
US3453284A (en) * 1966-01-19 1969-07-01 Du Pont Certain 2-(substituted-anilino)-2-oxazolines
DE1670751A1 (de) * 1966-09-27 1970-12-23 Bayer Ag Verfahren zur Herstellung von 2-Phenylamino-2-oxazolinen
US3622067A (en) * 1969-06-13 1971-11-23 Ok Partnership Ltd Document coder
BE754832A (fr) * 1969-08-14 1971-02-15 Beecham Group Ltd Iminazolines
USRE27133E (en) 1970-03-20 1971-06-01 Cdj)zco
GB1453703A (en) * 1972-12-28 1976-10-27 Science Union & Cie Substituted cyclopropylmethylamines processes for their preparation and pharmaceutical compositions containing them
US4102890A (en) * 1972-12-28 1978-07-25 Science-Union Et Cie, Societe Francaise De Recherche Medicale 2-Amino oxazolines and process for making the same
FR2269341B1 (xx) * 1974-04-30 1978-07-28 Castaigne Sa
GB1475513A (en) * 1974-06-20 1977-06-01 Science Union & Cie Benzylamine derivatives process for science union et cie benzylamine derivatives process for their production and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
AT350062B (de) 1979-05-10
GB1564268A (en) 1980-04-02
DE2723464C2 (de) 1983-08-11
US4315020A (en) 1982-02-09
ATA368277A (de) 1978-10-15
CH625795A5 (xx) 1981-10-15
ES459086A1 (es) 1978-04-16
JPS55127390A (en) 1980-10-02
NZ184175A (en) 1979-07-11
SU725561A3 (ru) 1980-03-30
OA05668A (fr) 1981-05-31
JPS5325565A (en) 1978-03-09
JPS584715B2 (ja) 1983-01-27
IL52137A (en) 1982-01-31
US4315019A (en) 1982-02-09
NL169182C (nl) 1982-06-16
NL169182B (nl) 1982-01-18
AU517715B2 (en) 1981-08-20
FR2358890B1 (xx) 1978-12-15
SE7705986L (sv) 1977-11-25
PH13880A (en) 1980-10-24
US4267345A (en) 1981-05-12
HU177039B (hu) 1981-06-28
PT66584B (fr) 1978-10-20
AR222022A1 (es) 1981-04-15
IL52137A0 (en) 1977-07-31
PT66584A (fr) 1977-06-01
FR2358890A1 (fr) 1978-02-17
GR61659B (en) 1978-12-05
NL7705727A (nl) 1977-11-28
AU2537677A (en) 1978-11-30
GB1564269A (en) 1980-04-02
SU791234A3 (ru) 1980-12-23
DE2723464A1 (de) 1977-12-08
AR219296A1 (es) 1980-08-15

Similar Documents

Publication Publication Date Title
NL930110I1 (nl) Carbazolyl-(4)-oxypropanolamine-derivaten werkwijze ter bereiding daarvan en geneesmiddelen die dezeverbindingen bevatten
FR2430410B1 (fr) Phenethanolamines et compositions pharmaceutiques en contenant
FR2345450A1 (fr) Quinoxalinones et quinoxalines, leurs procedes de preparation et composition pharmaceutique les contenant
BE879263A (fr) Compose de 2-methyl-dihydropyridine, procedes pour son obtention et composition pharmaceutique contenant ce compose
BE853422A (fr) Trans-hexahydro-pyrido-indoles, leur preparation et compositions pharmaceutiques les contenant
BE854908A (fr) Nouvelles aryl trifluoroethylamines, procedes d'obtention et les compositions pharmaceutiques en renfermant
BE856784A (fr) Nouvelles quinazolinones, leurs procedes d'obtention et leur application a la therapeutique
BE871857A (fr) Nouvelles piperazines disubstituees, leur procedes de preparation et les compositions pharmaceutiques les renfermant
FR2302102A1 (fr) Nouvelles substances antibiotiques derivees de l'antibiotique 67-694 et leurs procedes de preparation
FR2319351A1 (fr) Hydantoines et procedes d'obtention
FR2340310A1 (fr) Hydrazinophtalazines substituees, leur preparation et compositions pharmaceutiques les contenant
BE870801A (fr) Nouveaux thiopropionamides, leurs procedes d'obtention et les compositions pharmaceutiques en renfermant
FR2301267A1 (fr) Obtention d'enz
FR2333501A2 (fr) Nouveaux acetamides substitues leurs procedes d'obtention et les compositions pharmaceutiques en renfermant
BE838589A (fr) Nouveaux anilides, leurs procedes d'obtention et les compositions pharmaceutiques en renfermant
FR2347349A1 (fr) Derives d'acides phenoxymaloniques et composition herbicide les contenant
BE853444A (fr) Derives dipeptidiques, procedes pour les preparer et compositions pharmaceutiques en contenant
BE828633A (fr) Nouveaux indazoles, leurs procedes d'obtention et les compositions pharmaceutiques en renfermant
BE863802A (fr) Nouveaux derives d'everninomicine, leur procedes de preparation et compositions pharmaceutiques contenant lesdits derives
FR2343477A1 (fr) Nouvelles phenylpyridylhydantoines substituees et medicament les contenant
BE869639A (fr) 1-phenylethanolamines anti-inflammatoires, compositions pharmaceutiques en comprenant et procedes pour les produire
BE837877A (fr) Nouveaux dispirodecanes, leurs procedes d'obtention et les compositions pharmaceutiques en renfermant
FR2290900A1 (fr) Nouveaux ethers aryliques, leurs procedes d'obtention et les compositions pharmaceutiques en renfermant
BE861648A (fr) Compositions et procedes pharmaceutiques
FR2340724A2 (fr) Nouveaux diarylacetamides substitues, leurs procedes de preparation et les compositions pharmaceutiques en contenant